These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18165767)

  • 41. Evidence for the homeostatic regulation of induced beta cell mass expansion.
    Lipsett MA; Austin EB; Castellarin ML; Lemay J; Rosenberg L
    Diabetologia; 2006 Dec; 49(12):2910-9. PubMed ID: 17096119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo.
    Tanemura M; Ohmura Y; Deguchi T; Machida T; Tsukamoto R; Wada H; Kobayashi S; Marubashi S; Eguchi H; Ito T; Nagano H; Mori M; Doki Y
    Am J Transplant; 2012 Jan; 12(1):102-14. PubMed ID: 21966953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment.
    Gilliam BL; Heredia A; Devico A; Le N; Bamba D; Bryant JL; Pauza CD; Redfield RR
    AIDS; 2007 Oct; 21(15):2108-10. PubMed ID: 17885304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of rapamycin on lifespan in Drosophila.
    Harrison B; Tran TT; Taylor D; Lee SD; Min KJ
    Geriatr Gerontol Int; 2010 Jan; 10(1):110-2. PubMed ID: 20102391
    [No Abstract]   [Full Text] [Related]  

  • 45. Rapamycin (sirolimus) inhibits heart cell growth in vitro.
    Burton PB; Yacoub MH; Barton PJ
    Pediatr Cardiol; 1998; 19(6):468-70. PubMed ID: 9770573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin and dendritic cells: keep on movin'.
    Hackstein H
    Transplantation; 2006 Sep; 82(6):739-40. PubMed ID: 17006318
    [No Abstract]   [Full Text] [Related]  

  • 47. Differential Effects of Rapamycin on Glucose Metabolism in Nine Inbred Strains.
    Reifsnyder PC; Te A; Harrison DE
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):50-57. PubMed ID: 31276577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucosamine-conjugated nanoparticles for the separation of insulin-secreting beta cells.
    Narayanan K; Lin AW; Zheng Y; Erathodiyil N; Wan AC; Ying JY
    Adv Healthc Mater; 2013 Sep; 2(9):1198-203. PubMed ID: 23471896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability.
    Burke JA; Zhang X; Bobbala S; Frey MA; Bohorquez Fuentes C; Freire Haddad H; Allen SD; Richardson RAK; Ameer GA; Scott EA
    Nat Nanotechnol; 2022 Mar; 17(3):319-330. PubMed ID: 35039683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In situ quantification of pancreatic beta-cell mass in mice.
    Kim A; Kilimnik G; Hara M
    J Vis Exp; 2010 Jun; (40):. PubMed ID: 20548281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ["Free" and "bound" insulin in serum from patients with beta-islet cell adenoma].
    BUERGI H; RAMSEIER EB; FORESCH ER; BALLY P; LABHART A
    Helv Med Acta; 1962 Dec; 29():527-34. PubMed ID: 14016649
    [No Abstract]   [Full Text] [Related]  

  • 52. Total synthesis of rapamycin.
    Maddess ML; Tackett MN; Watanabe H; Brennan PE; Spilling CD; Scott JS; Osborn DP; Ley SV
    Angew Chem Int Ed Engl; 2007; 46(4):591-7. PubMed ID: 17154218
    [No Abstract]   [Full Text] [Related]  

  • 53. beta-Cell proliferation is the major source of new pancreatic beta cells.
    Dor Y
    Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):242-3. PubMed ID: 16932291
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of the effects on the mitoses of plant cells of 1.4 dimethylsulfonoxybutane. Trials of protection by beta-mercaptoethylamine].
    TRUHAUT R; DEYSSON G
    C R Hebd Seances Acad Sci; 1954 May; 238(18):1833-5. PubMed ID: 13161254
    [No Abstract]   [Full Text] [Related]  

  • 55. Exploring the molecular mechanisms of macrophages in islet transplantation using single-cell analysis.
    Pu Z; Chen S; Lu Y; Wu Z; Cai Z; Mou L
    Front Immunol; 2024; 15():1407118. PubMed ID: 39267737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor.
    Lin L; Pan X; Feng Y; Yang J
    Ther Adv Endocrinol Metab; 2024; 15():20420188241252309. PubMed ID: 39071115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of Experimental Autoimmune Diabetes With an sCD39/Anti-CD3 Treatment.
    Fotino C; Molano RD; Ben Nasr M; Umland O; Fraker CA; Ulissi U; Balasubramanian HB; Lunati ME; Usuelli V; Seelam AJ; Khalefa SA; La Sala C; Gimeno J; Mendez AJ; Ricordi C; Bayer AL; Fiorina P; Pileggi A
    Diabetes; 2023 Nov; 72(11):1641-1651. PubMed ID: 37625134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes.
    Belenchia AM; Boukhalfa A; DeMarco VG; Mehm A; Mahmood A; Liu P; Tang Y; Gavini MP; Mooney B; Chen HH; Pulakat L
    Cells; 2023 May; 12(10):. PubMed ID: 37408206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges.
    Silva IBB; Kimura CH; Colantoni VP; Sogayar MC
    Stem Cell Res Ther; 2022 Jul; 13(1):309. PubMed ID: 35840987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
    Wang X; Brown NK; Wang B; Shariati K; Wang K; Fuchs S; Melero-Martin JM; Ma M
    Adv Sci (Weinh); 2021 Sep; 8(17):e2003708. PubMed ID: 34258870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.